Market Research Logo

Tekmira Pharmaceuticals Corp. - Product Pipeline Review - 2015

Tekmira Pharmaceuticals Corp. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Tekmira Pharmaceuticals Corp. - Product Pipeline Review - 2015’, provides an overview of the Tekmira Pharmaceuticals Corp.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Tekmira Pharmaceuticals Corp.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Tekmira Pharmaceuticals Corp. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Tekmira Pharmaceuticals Corp.’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Tekmira Pharmaceuticals Corp.’s pipeline products
Reasons to buy
  • Evaluate Tekmira Pharmaceuticals Corp.’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Tekmira Pharmaceuticals Corp. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Tekmira Pharmaceuticals Corp.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Tekmira Pharmaceuticals Corp. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Tekmira Pharmaceuticals Corp.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Tekmira Pharmaceuticals Corp. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues


Tekmira Pharmaceuticals Corp. Snapshot
Tekmira Pharmaceuticals Corp. Overview
Key Information
Key Facts
Tekmira Pharmaceuticals Corp. - Research and Development Overview
Key Therapeutic Areas
Tekmira Pharmaceuticals Corp. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
Tekmira Pharmaceuticals Corp. - Pipeline Products Glance
Tekmira Pharmaceuticals Corp. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Tekmira Pharmaceuticals Corp. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Tekmira Pharmaceuticals Corp. - Drug Profiles
TKM-Ebola-Guinea
Product Description
Mechanism of Action
R&D Progress
TKM-PLK1
Product Description
Mechanism of Action
R&D Progress
TKM-100802
Product Description
Mechanism of Action
R&D Progress
TKMHBV-1
Product Description
Mechanism of Action
R&D Progress
TKMHBV-2
Product Description
Mechanism of Action
R&D Progress
CCC-0346
Product Description
Mechanism of Action
R&D Progress
CCC-0975
Product Description
Mechanism of Action
R&D Progress
CYT-003-QbG10
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit HBsAg for Hepatitis B
Product Description
Mechanism of Action
R&D Progress
NVP-018
Product Description
Mechanism of Action
R&D Progress
RNAi Oligonucleotide to Inhibit CSN5 for Hepatocellular Carcinoma
Product Description
Mechanism of Action
R&D Progress
RNAi Oligonucleotide to Inhibit WEE1 for Hepatocellular Carcinoma
Product Description
Mechanism of Action
R&D Progress
TKM-ALDH2
Product Description
Mechanism of Action
R&D Progress
TKM-GSD
Product Description
Mechanism of Action
R&D Progress
TKM-HTG
Product Description
Mechanism of Action
R&D Progress
TKM-Marburg
Product Description
Mechanism of Action
R&D Progress
TKMApoC-3
Product Description
Mechanism of Action
R&D Progress
DVR-23
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Dengue
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Hepatitis B Infections
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Agonize Sting Receptor for Hepatitis B
Product Description
Mechanism of Action
R&D Progress
Tekmira Pharmaceuticals Corp. - Pipeline Analysis
Tekmira Pharmaceuticals Corp. - Pipeline Products by Target
Tekmira Pharmaceuticals Corp. - Pipeline Products by Route of Administration
Tekmira Pharmaceuticals Corp. - Pipeline Products by Molecule Type
Tekmira Pharmaceuticals Corp. - Pipeline Products by Mechanism of Action
Tekmira Pharmaceuticals Corp. - Recent Pipeline Updates
Tekmira Pharmaceuticals Corp. - Dormant Projects
Tekmira Pharmaceuticals Corp. - Company Statement
Tekmira Pharmaceuticals Corp. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Tekmira Pharmaceuticals Corp., Key Information
Tekmira Pharmaceuticals Corp., Key Facts
Tekmira Pharmaceuticals Corp. - Pipeline by Indication, 2015
Tekmira Pharmaceuticals Corp. - Pipeline by Stage of Development, 2015
Tekmira Pharmaceuticals Corp. - Monotherapy Products in Pipeline, 2015
Tekmira Pharmaceuticals Corp. - Partnered Products in Pipeline, 2015
Tekmira Pharmaceuticals Corp. - Partnered Products/ Combination Treatment Modalities, 2015
Tekmira Pharmaceuticals Corp. - Out-Licensed Products in Pipeline, 2015
Tekmira Pharmaceuticals Corp. - Out-Licensed Products/ Combination Treatment Modalities, 2015
Tekmira Pharmaceuticals Corp. - Phase II, 2015
Tekmira Pharmaceuticals Corp. - Phase I, 2015
Tekmira Pharmaceuticals Corp. - Preclinical, 2015
Tekmira Pharmaceuticals Corp. - Discovery, 2015
Tekmira Pharmaceuticals Corp. - Pipeline by Target, 2015
Tekmira Pharmaceuticals Corp. - Pipeline by Route of Administration, 2015
Tekmira Pharmaceuticals Corp. - Pipeline by Molecule Type, 2015
Tekmira Pharmaceuticals Corp. - Pipeline Products by Mechanism of Action, 2015
Tekmira Pharmaceuticals Corp. - Recent Pipeline Updates, 2015
Tekmira Pharmaceuticals Corp. - Dormant Developmental Projects,2015
Tekmira Pharmaceuticals Corp., Subsidiaries
List of Figures
Tekmira Pharmaceuticals Corp. - Pipeline by Top 10 Indication, 2015
Tekmira Pharmaceuticals Corp. - Pipeline by Stage of Development, 2015
Tekmira Pharmaceuticals Corp. - Monotherapy Products in Pipeline, 2015
Tekmira Pharmaceuticals Corp. - Partnered Products in Pipeline, 2015
Tekmira Pharmaceuticals Corp. - Out-Licensed Products in Pipeline, 2015
Tekmira Pharmaceuticals Corp. - Pipeline by Top 10 Target, 2015
Tekmira Pharmaceuticals Corp. - Pipeline by Top 10 Route of Administration, 2015
Tekmira Pharmaceuticals Corp. - Pipeline by Top 10 Molecule Type, 2015
Tekmira Pharmaceuticals Corp. - Pipeline Products by Top 10 Mechanism of Action, 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report